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Abstract
Protein phosphorylation is involved in posttranslational control of essentially all biological processes. Using mass
spectrometry, recent analyses of whole phosphoproteomes led to the identification of numerous new phosphorylation
sites. However, the function of most of these sites remained unknown. We chose the Drosophila Bicaudal-D protein to
estimate the importance of individual phosphorylation events. Being involved in different cellular processes, BicD is required
for oocyte determination, for RNA transport during oogenesis and embryogenesis, and for photoreceptor nuclei migration
in the developing eye. The numerous roles of BicD and the available evidence for functional importance of BicD
phosphorylation led us to identify eight phosphorylation sites of BicD, and we tested a total of 14 identified and suspected
phosphoserine residues for their functional importance in vivo in flies. Surprisingly, all these serines turned out to be
dispensable for providing sufficient basal BicD activity for normal growth and development. However, in a genetically
sensitized background where the BicD
A40V protein variant provides only partial activity, serine 103 substitutions are not
neutral anymore, but show surprising differences. The S103D substitution completely inactivates the protein, whereas
S103A behaves neutral, and the S103F substitution, isolated in a genetic screen, restores BicD
A40V function. Our results
suggest that many BicD phosphorylation events may either be fortuitous or play a modulating function as shown for Ser
103.
Remarkably, amongst the Drosophila serines we found phosphorylated, Ser
103 is the only one that is fully conserved in
mammalian BicD.
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Introduction
Reversible phosphorylation of proteins at Ser, Thr and Tyr
residues is a particularly important type of a posttranslational
modification because it is involved in the control of essentially all
biological processes. For this reason, protein phosphorylation has
drawn widespread interest, and a number of techniques have been
developed and were successfully applied to investigate the
phosphorylation states and sites of isolated proteins. A combina-
tion of recent advancements in genomics and mass spectrometric
analysis of peptides opened the possibility to analyze phosphor-
ylation of whole proteomes, allowing the identification of many
new phosphorylation sites (see e. g. [1–3]). However, the functions
of these newly discovered phosphorylation events are usually not
clear.
To estimate the importance of individual phosphorylation
events, we set out to systematically verify the phosphorylation sites
of one polypeptide, and to test these genetically for their functional
importance. To increase the chances of identifying functional roles
for these sites, we chose the Drosophila Bicaudal-D (BicD) protein
that is phosphorylated [4] and has many essential functions during
various phases of the life cycle of the fly [5]. In addition, there is
evidence that the kinases polo [6] and misshapen [7] may
phosphorylate Drosophila BicD, and the human Glycogen synthase
kinase-3b (GSK-3b) can phosphorylate human BicD1 in vitro [8].
Furthermore, phenotypic correlations between phosphorylation
and mutant phenotypes had already been described. The BicD
allele BicD
PA66, an alanine to valine substitution at amino acid 40,
is a recessive hypomorphic mutant that is viable, but female sterile
because their ovaries fail to differentiate an oocyte and egg. In
these mutant ovaries, phosphorylation of the BicD
A40V protein is
markedly reduced [4]. In addition, a suppressor of this allele,
BicD
PA66 Su(66), restores female fertility as well as BicD
phosphorylation levels [4]. BicD functions in numerous different
processes, and we will therefore briefly summarize these functions
to give an impression of the various tests we set up.
During early oogenesis, BicD is required for the determination
and differentiation of an oocyte from a cluster of 16 intercon-
nected germ cells. While the remaining 15 become nurse cells, the
oocyte relocalizes in a BicD-dependent manner to the posterior of
the developing egg chamber. In this process, BicD works together
with egl, Lis-1 and Dynein in a microtubule based process (reviewed
in [5]), and the same machinery seems to function subsequently in
delivering primary axis determination mRNAs (see e. g. [9]). Also
during oogenesis, but as part of different processes with distinct
requirements for additional genes, BicD localizes organelles and
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embryogenesis, the BicD-dependent RNA transport machinery is
used again for the apical localization of pair-rule and wingless
transcripts [15–17]. At the third instar larval stage, formation of
the ommatidia of the compound eye starts and the nuclei of the
differentiating photoreceptor cells migrate to the apical surface
[18]. This apical migration is dependent on BicD, Lis-1, and the
microtubule motors Dynein and Kinesin [7,10,19]. The highly
regular geometry of the compound eye makes this a very sensitive
system to study the effect of slight alterations of the activities of
genes involved in its development. To systematically test the
function of suspected and identified phosphorylation sites in BicD,
we made mutants in vitro that cannot be phosphorylated at these
sites (Ser to Ala or Asn substitutions) and mutants that mimic
permanent phosphorylation of some of these sites (Ser to Asp). We
then produced transgenic lines and crossed them into the BicD
null
mutant background [20] to test whether the mutant alleles were
capable to substitute for the normal BicD in the various processes
described.
Surprisingly, these phosphosites turned out not to be essential
for any of the described BicD functions, suggesting that they are
either redundant, only modulating or even fortuitous events. While
limited tests for redundant functions also failed to uncover such
events, one site turned out to be important for overall BicD
phosphorylation levels. However, this mutant did still not reveal
any other BicD phenotype, further arguing against essential
functions of BicD phosphorylation in normal development. With
the help of a genetically identified suppressor mutation that rescues
BicD
A40V hypophosphorylation, we finally found evidence for a
modulating role of Ser
103. In the background of the only partially
functional BicD
A40V variant, the side chain of position 103
becomes crucial for BicD function, even though it is not in the wild
type background. While a S103A substitution does not change the
BicD
A40V phenotype, the permanent phospho-mimic mutant
S103D fully inactivates the protein, and a S103F mutant restores
its activity significantly. If an extrapolation from our results is
valid, most phosphorylation events may be fortuitous and play
only a modulating role if any.
Results
Multiple phosphorylation sites in BicD
An initial analysis of BicD phosphorylation using in vivo
32P
phosphate labeled ovaries combined with phospho-amino acid
analysis revealed only significant phosphoserine signal, indicating
that phosphorylation of ovarian BicD takes place preferentially at
serines. CNBr mapping data further indicated that these
phosphoserines are primarily present in the N-terminal region
(peptide 21–138; S. Larochelle and B. Suter, personal communi-
cation). To identify BicD phosphorylation sites, we immunopre-
cipitated unlabeled protein from ovarian and embryonic extracts.
Bands corresponding to BicD were excised from the gel and
analyzed by mass spectrometry. Alternatively, BicD::GFP [21] was
immunoprecipitated from embryo extracts with anti-GFP anti-
bodies coupled to beads and analyzed by MS without a gel
purification step. Phosphopeptides were subjected to tandem MS
analysis to identify phosphorylated residues, as shown exemplarily
for the peptide T
91-R
106 in Figure 1A and B (phosphorylated). The
obtained data allowed unambiguous identification of phosphory-
lated serines at Ser
14, Ser
103, Ser
186, Ser
305 and Ser
310. The latter
two, Ser
305 and Ser
310, were also found to be simultaneously
phosphorylated, as revealed by the identification of the doubly
phosphorylated peptide R
299/L
300EADLpSTELKpSPDGTK
315
with one or two missed cleavage sites. In addition, we found Ser
288
to be phosphorylated, either alone, or together with Ser
285, while
we did not see Ser
285 phosphorylation independently of pSer
288.
Moreover, either Thr
108 or Ser
109 become phosphorylated, but the
lack of discriminative product ions did not allow unambiguous
allocation of the phosphorylation site. Figure 1C summarizes the
phosphorylation sites we identified. Phosphorylation of threonine
or tyrosine was not observed in the MS analysis, which is in
agreement with the earlier in vivo labeling result.
MS-identified phosphorylation sites are all located within the N-
terminal half of BicD (Figure 1D). Remarkably, the Ser
103 and
Ser
186 are conserved in human and mouse BicD, and they are
situated each in regions that are highly conserved between fly,
human and mouse BicD isoforms (Figure 1E), though S
186 is
substituted by a Thr in BicD1. All other serines, 14, 109, 285/288
and 305/310 are not conserved however, although Ser
109
corresponds to a phosphorylatable tyrosine in mammalian BicD
(Figure 1E). Evolutionary conservation is only one indication of
functional importance and for Ser
14 there is additional evidence.
The sequence around Ser
14 is a perfect match to a Polo kinase
target site according to the consensus sequence D/E-X-S/T-W-X-
D/E [22], where W denotes any hydrophobic residue. A Polo
kinase target site is of particular interest because over-expression of
Polo kinase in the germ line of BicD
PA66 females was reported to
restore oocyte formation in most egg chambers and also normal
distribution of the BicD
PA66 protein [6]. Surprisingly, even though
this PA66 mutation (A40V) affects overall BicD phosphorylation
drastically [4] and the region around this substitution contains five
serines between positions 33 and 45, none of them show any
detectable Ser phosphorylation (Table 1). This was also unexpect-
ed because a similar Ser/Ala-rich region had been identified to be
phosphorylated [23]. This finding indicates that these sites are
either not phosphorylated or that these modifications are only
short-lived.
Testing the functional importance of BicD
phosphorylation
To investigate the importance of phosphorylation for BicD
function, a systematic mutagenesis study was carried out.
Mutations changing the identified and candidate phosphorylation
target sites were introduced by site directed mutagenesis into a
functional, untagged mini-BicD gene, that is expressed from its
native promoter and is also used as the wild type control gene
(BicD
wt; see Materials and Methods section for details). Accord-
ingly, we made phosphorylation-impaired mutants for the serines
shown in Figure 1C by substituting the respective codons
individually with alanine codons. To investigate the possibility
that transient phosphorylation of the serines in the vicinity of the
PA66 mutation (serines 33, 34, 36, 39, 45, 51 and 84) plays a
functional role, we also tested mutations that change these Ser into
Ala. At the same time we also tested for functional redundancy
between sites in the serine 33–45 cluster. For this we made a
quintuple mutation in which these Ser were replaced with Ala or
Asn codons. For Ser
14, Ser
103 and Ser
310, we additionally made
phospho-mimic aspartic acid substitutions. Transgenic fly lines
were established for all mutants and the constructs were crossed
into hemizygous BicD
null flies to test for their ability to restore
viability and female fertility of the BicD
null mutants. In this assay,
the transgenic BicD
wt construct was able to completely rescue
viability and fertility of the null mutants, while a female sterile
allele BicD
PA66, reconstructed in the same mini gene (BicD
A40V),
produces viable but sterile females. Therefore, the mini-BicD rescue
constructs show the same effects as the endogenous alleles and the
assay system is thus validated.
BicD Serine Phosphorylation
PLoS ONE | www.plosone.org 2 February 2009 | Volume 4 | Issue 2 | e4552Figure 1. Location of BicD phosphorylation sites. A, B: MS/MS spectra of the [M+2H]
2+ ions of the peptide T
91GIEQEDALLNESAAR
106 (A) and its
serine phosphorylated form (B). The intense, neutral loss fragment at m/z=850.4 (marked with an asterisk) in B indicates the extensive loss of
phosphoric acid. Upon collision induced fragmentation in the iontrap, peptide bond fragmentation allowed unambiguous characterization of the
amino acid sequence and the presence of a phosphorylated Ser. Note the m/z shift of 80 mass units corresponding to the phosphorylation of serine
at y(4) and following y- ions between A and B. Furthermore, y-ions showed also extensive loss of phosphoric acid corresponding to a y-ion series with
98 mass units difference in the same MS/MS spectrum in B. C: Summary of phosphopeptides and phosphorylation sites of BicD identified by MS
analysis. Phosphorylation of Ser
285 was only observed when Ser
288 was phosphorylated as well. Of Ser
305 and Ser
310, both, single and double
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the associated phenotypes. Surprisingly, all Ser mutant constructs
were able to rescue the lethality and the sterility of the BicD
null
allele, indicating that phosphorylation of these individual serines is
not absolutely required to provide basal levels of essential BicD
functions, and that the function of BicD in oogenesis cannot be
dramatically impaired by any of these mutants. In addition,
mimicking permanent phosphorylation of Ser
14, Ser
103 and Ser
310
also appears not to have a major effect on BicD function.
Wild type BicD preferentially accumulates in the oocyte, and a
significant amount of the protein is hyperphosphorylated. In
BicD
PA66 mutants however, no oocyte is formed and the levels of
hyperphosphorylated BicD are reduced [4]. To further test the
correlation between BicD function and the presence of the
hyperphosphorylated isoform of BicD, we analyzed the BicD
isoform pattern in the newly established phosphomutants. For this
purpose, BicD was immunoprecipitated from wt and mutant ovary
extracts and its isoforms were separated by gel electrophoresis and
visualized by western blotting. In control extracts from rescued
wild type and OregonR females, there were two distinct isoforms
of BicD present (Figure 2A, lanes 1 and 2, respectively). The BicD-
antibody complex immunoprecipitated from OreR extracts was
additionally treated with Calf Intestinal Phosphatase (CIP), which
led to the disappearance of the slow migrating isoform (lane 3).
Treatment in the presence of phosphatase inhibitors did not
change the isoform pattern (lane 4), confirming that the slow
migrating band is indeed a hyperphosphorylated isoform of BicD.
Consistent with its normal physiological function, the isoform
pattern of the wild type rescue construct was comparable to the
one of the OreR controls (lanes 1 and 2), while the reconstructed
BicD
PA66 mutant lead to a significant reduction of the slowest
migrating band (lane 8), as had been reported for endogenous
BicD
A40V [4].
Mutating the serines 14 through 288 has little effect on the
global phosphorylation levels of BicD, and the patterns and the
individual band intensities of BicD in these mutants appear similar
to the wild type controls (Figure 2A, lanes 5, 6 and 12–23).
Interestingly, in the case of Ser
14 and Ser
103, neither mimicking
permanent phosphorylation nor preventing phosphorylation
influences overall phosphorylation levels of BicD (Figure 2B and
2A, lanes 12, 13 and 5, 6, respectively). To further verify this visual
impression, we quantitatively assayed the amount of phospho-
BicD in these mutants. The graph in Figure 2B shows the amount
of the phospho-isoforms of every mutant relative to the wild type
rescue construct that was set to 100% (black columns). Because we
could not see a major change of BicD protein content in any of the
Ser mutants, we assumed that reduced hyperphosphorylation of
BicD leads to a higher level of the hypophosphorylated isoform,
rather than to degradation. Accordingly, the values of hyperpho-
spho-BicD were normalized to the sum of both BicD bands in each
individual sample. The quantification results confirmed the visual
impression and revealed only minor differences in hyperpho-
sphorylation of BicD between most mutants. We also repeated this
phospho-BicD analysis with loading ovarian extracts directly on
the gel and obtained the same results (Figure 2B, grey columns),
indicating that the ratios are not distorted by differential
immunoprecipitation of different isoforms.
While these findings are in agreement with a positive correlation
between phospho-BicD levels and BicD function, the Ser
310
mutants seems to be an exception to this. They are viable and
normally fertile, but show a markedly reduced amount of
hyperphosphorylated BicD, irrespective of whether phosphoryla-
tion of this residue is prevented or mimicked (Figure 2B and 2A,
lanes 24 and 25). Because the Ser
310 alleles are functional, while
Table 1. Phenotypes of BicD phosphorylation mutants.
Mutation
MS
identification Phenotype
phos. non-phos.
wild type ff
S14A + 2 ff
S14D ff
S33A 2 + ff
S34A 2 + ff
S36A 2 + ff
S39A 2 + ff
S45A 2 + ff
multiple ff
S51A 22 ff
S84A 22 ff
S103A ++ ff
S103D ff
S103F ff
S109A ++ ff
S186A ++ ff
S285A ++ ff
S288A ++ ff
S285A+S288A ff
S305 ++ ff
S310A ++ ff
S310D ff
S305A+S310A ff
A40V fs, 16 nurse cells
A40V+S103A fs, 16 nurse cells
A40V+S103D lethal with few adults, 16 nurse cells
A40V+S103F ff, few egg chambers with 16 nurse cells
Peptides containing the indicated serines were identified (+) as serine
phosphorylated form (phos.) or non-phosphorylated (non-phos.), or the peptide
was never identified (2). All mutants are viable, except for BicD
A40V, S103D.
BicD
multiple consists of the five substitutions S33A, S34N, S36N, S39A, S45A.
ff females fertile.
fs females sterile.
doi:10.1371/journal.pone.0004552.t001
phosphorylations, were found. The peptide 12–24 is an incomplete tryptic fragment, whereas the shown peptide 299–315 has two missed cleavage
sites. Due to its small size, the peptide S
310PDGTK
315 could not be identified individually. D: Schematic drawing of the BicD protein. The positions of
phosphoserines identified by MS analysis are indicated on top. Additional mutants created for this study are indicated at the bottom. Coiled-coil
domains were predicted using the program MARCOIL [43], and are shaded in dark grey (probability $90%). Drawing is to scale. E: Amino acid
alignment of the BicD N-terminal part. The sequences of human BicD1 and 2 (H.s. 1, H.s. 2; SwissProt entries Q96G01 and Q8TD16, respectively),
mouse BicD1 and 2 (M.m. 1, M.m. 2; Q8BR07, Q921C5) and Drosophila BicD (D.m.; P16568) were aligned using the program T-COFFEE [44].
Phosphorylated serines in Drosophila BicD are marked by black triangles, ambiguous sites are indicated by grey triangles.
doi:10.1371/journal.pone.0004552.g001
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A40V mutation is solely reduced BicD phosphorylation.
BicD has additional zygotic functions later in development,
where it is required for the positioning of the photoreceptor nuclei
[10]. Analyzing the eyes of BicD
null flies reveals a rough eye
phenotype with irregularly shaped ommatidia (data not shown; see
later). To test whether one of our serine mutants plays a role
specifically in this pathway, we inspected the eyes of these mutants
and found them to be normal, suggesting that BicD phosphory-
lation is also dispensable for this process (data not shown).
Substituting Ser
103 by phenylalanine in BicD
A40V
suppresses the BicD
PA66 phenotype and increases
phospho-BicD levels
While phosphorylation of the 14 tested serines is not essential
for basal BicD function, it may play a more modulating role that
can be detected under less favorable conditions. A genetic screen
for a suppressor of the phosphorylation mutant BicD
PA66 lead to
the isolation of the Su(66) mutation that significantly restores the
accumulation of hyperphosphorylated BicD protein [4]. In
addition, the suppressor mutation also restores female fertility
and oocyte localization of BicD. As these observations point to a
functional importance of BicD phosphorylation, we set out to
study the molecular basis of this phenotype. The Su(66) mutation
maps to the second chromosome and recombination mapping
experiments placed Su(66) in the immediate vicinity of BicD (A.
Swan and B. Suter, personal communication). In order to identify
this suppressor mutation, we sequenced BicD and its four proximal
neighboring genes Sgt, Aac11, fws and CG5110 from homozygous
BicD
PA66 Su(66) flies. The sequences were compared to the
parental BicD
PA66 chromosome. No polymorphism was detected in
the four proximal genes and the BicD
PA66 mutation was present on
the BicD
PA66 Su(66) chromosome as expected. In addition, we
found in the BicD gene a single nucleotide transition CRT that
was not present in the parental BicD
PA66 strain. This mutation
changes the codon 103 from TCC to TTC, causing the normally
present serine to be substituted by a phenylalanine in Su(66). This
substitution was of exceptional interest, because our MS analysis
identified this Ser
103 to be phosphorylated. In order to test
whether the S103F substitution indeed acts as suppressor of the
BicD
PA66 allele, we reconstructed this BicD allele with both
Figure 2. BicD phosphorylation in phosphorylation target site mutants. BicD protein isoforms were separated by PAGE and detected by
Western blotting. A: A representative blot with BicD protein immunoprecipitated from the indicated ovarian extracts. All samples were processed
simultaneously. The slowest migrating isoform corresponds to hyperphosphorylated BicD (marked with an arrowhead), as demonstrated by
treatment of immunoprecipitates from OregonR females without (OreR) and with Phosphatase (+CIP), or with Phosphatase in presence of inhibitors
(+CIP +Inh.). In addition, the reconstruction of the BicD
PA66 mutant (A40V) served as internal control, where the slow migrating isoform is reduced.
Beads: mock IP from OreR extracts without antibody. The dashed vertical line indicates the border between different gels/blots. Due to the small
ovary size of the female sterile mutants, less total material was loaded in lanes 8 and 9. B: For quantification, the amount of phospho-BicD was
determined relative to the not mutated rescue construct (wt) that was set to 100%. All values are normalized to the sum of both bands to
compensate for different total amounts loaded. Black columns: percentage of phospho-BicD determined from immunoprecipitation and the blot
shown in panel A. Grey columns: percentage of phospho-BicD obtained from ovarian extracts without IP. BicD
multiple consists of the five substitutions
S33A, S34N, S36N, S39A, S45A. Su(66): extracts from homozygous BicD
PA66 Su(66) cn females. PA66: extracts from homozygous BicD
PA66 cn bw females.
*: no data.
doi:10.1371/journal.pone.0004552.g002
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chromosome BicD
A40V, S103F were viable and fertile, while the ones
with BicD
A40V alone are viable but sterile.
In order to study the effects of this mutation, we analyzed the
influence of residue 103 on the distribution of the protein during
oogenesis.Atfirstglance,ovariesofBicD
A40V,S103Ffliesappearlargely
normal and contain mostly egg chambers with normal morphology
(Figure 3). The mutant BicD protein accumulates in the oocyte and
displays a normal subcellular distribution. However, the accumula-
tion appears less pronounced compared to the wild type situation
(Figure3A,F),suggestingthatthedoublemutantBicDproteinisless
active than wild type BicD. Moreover, such BicD
A40V, S103F ovaries
contain a few egg chambers that failed to form an oocyte, and,
instead,contain16polyploidnursecells(arrowinFigure3C,H),like
all egg chambers from control BicD
A40V females do (Figure 3B, G).
Thisisconsistentwithourpreviousobservations[4],confirmingthat
the S103F substitution is sufficient to partially suppress the effects of
the BicD
A40V mutation.
Ser
103 substitutions alter the BicD
A40V phenotype in a
mutant specific manner
Because phenylalanine is not phosphorylatable, we wondered
whetherpreventingSer
103phosphorylationissufficienttosuppressthe
BicD
PA66 phenotype. To test this, we constructed the BicD
A40V, S103A
allele, where the Ser
103 is replaced by an alanine, which cannot be
phosphorylated either. Surprisingly however, such BicD
A40V, S103A
females were sterile with ovaries consisting of egg chambers with 16
nurse cells and no oocyte (Figure 3D, I), indistinguishable from the
phenotypeofBicD
A40Vfemalesthathavethewildtypeserineatposition
103. Therefore, the suppression effect of the S103F substitution on
BicD
A40V cannot be caused simply by inhibition of phosphorylation
of Ser
103.
We next wondered how mimicking permanent phosphorylation
of Ser
103 in BicD
A40V affects the function of the protein. Strikingly,
BicD with both substitutions, A40V and S103D, does not rescue
BicD
null alleles and thus behaves like a recessive lethal mutant.
Only very few BicD
A40V, S103D adults were obtained, they hatched
2–4 days later and were smaller than control siblings with an
endogenous copy of wild type BicD from the CyO chromosome
(Figure 4A–C), appearing weak and lethargic and displaying
uncoordinated behavior. These mutants died within a few days. In
addition, they had a variable rough eye phenotype because of
irregular ommatidia (compare Figure 4D–F), while the viable
BicD
A40V, S103A and BicD
A40V, S103F mutants displayed normal eyes
(Figure 4G and H, respectively). Ovaries of BicD
A40V, S103D females
consist of egg chambers lacking an oocyte and containing only 16
polyploid nurse cells (Figure 3E and J), similar to ovaries from
BicD
PA66 and BicD
null flies (Figure 3B, and [20,24]). In addition, the
BicD
A40V, S103D protein does not accumulate into a single cell. All
these described phenotypes were previously reported for BicD
null
flies [10,20]. These findings therefore strongly suggest that
mimicking permanent phosphorylation at amino acid position
103 of BicD
A40V severely inhibits even the essential zygotic
functions of BicD
A40V.
Effect of amino acid 103 on BicD function
In an otherwise wild type BicD, substituting the Ser
103 by A, D
or F does not yield any obvious phenotypes. We were therefore
surprised by the strikingly different phenotypes observed when
these substitutions were combined with the A40V mutation found
in BicD
PA66. Consequently, we also analyzed the function of
residue 103 in the wild type protein in more detail. The S103A/
D/F mutants were viable and fertile (Table 1). However, the
phospho-mimic BicD
S103D mutant seems to have slightly less
hyperphosphorylated BicD than the phosphorylation defective
mutants BicD
S103F and BicD
S103A (Figure 2B and 2A, lanes 5–7).
Ovaries of BicD
S103X females appear normal, and while the S103A
mutant protein accumulates normally in the oocyte, the BicD
S103D
Figure 3. A S103F substitution in BicD
A40V suppresses the BicD
PA66 phenotype. Confocal images of ovaries from the indicated wt and mutant
females, stained with anti-BicD antibodies (red). Blue: DNA, green: F-actin. A, F: In ovaries with wild type BicD, all egg chambers contain an oocyte,
and the protein accumulates in the oocyte throughout oogenesis. The BicD mutants A40V (B, G) fail to form an oocyte, and egg chambers contain 16
nurse cells. The mutant protein does not accumulate in a single cell. C, H: Substitution of Ser
103 by phenylalanine in BicD
A40V suppresses the BicD
PA66
phenotype. Most egg chambers form an oocyte, where the BicD protein accumulates to a certain extent. The egg chamber indicated by an arrow
contains 16 polyploid nurse cells and no oocyte. D, I: The mutants A40V+S103A and A40V+S103D (E, J) also fail to form an oocyte. Shown are
maximum projections of z-stacks. Panels F–J: for clarity reasons, individual panels are composed of different optical sections.
doi:10.1371/journal.pone.0004552.g003
BicD Serine Phosphorylation
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increased oocyte accumulation (Supporting Figure S1). These
findings suggest that mimicking permanent phosphorylation of
BicD at Ser
103 acts inhibitory on the protein’s oocyte localization.
Another assay to test the activity of the Ser
103 mutants is to
investigate whether these mutants affect the dominant BicD
phenotype. Females with the BicD
2 allele produce embryos with
defective anterior structures [24,25] caused by a partial mislocaliza-
tion of osk mRNA to the anterior of the oocyte and the embryo
[26,27]. Embryos from females hemizygous for BicD
2 and with one
copy of the wild type rescue transgene (BicD
wt) or a Ser
103 mutant
construct were inspected for defective anterior structures (Figure 5).
With the BicD
wt transgene, such mothers produce mostly normal
embryos (wt). Similarly, low numbers of aberrant embryos are
observed when the mothers had the S103A or S103F substitution in
the BicD transgene. In contrast, a markedly increased amount of
defective embryos was found when mothers carried the BicD
S103D
allele. These results provide further evidence that the amino acid at
position103isimportantforfullBicDfunction,andtheysuggestthat
transient phosphorylation of the native serine at this position plays a
role in modulating BicD function.
Discussion
Protein phosphorylation is a posttranslational modification that
is used to regulate the function of proteins involved in many
different cellular processes. The widespread interest in this
reversible protein modification recently led to the analysis of
phosphoproteomes (see e. g. [28,29]) which revealed many new
phosphorylation sites. However, the function of these phosphor-
ylation events usually remained to be elucidated. To obtain an
estimate of the function of the numerous phosphorylation sites
determined with this technique, we picked a protein that is known
to be phosphorylated, determined its phosphorylation sites,
compared these sites with the proteomics data, analyzed the
evolutionary conservation of the sites, and tested the requirement
for phosphorylation of these residues. Our choice of example
protein was the Drosophila BicD because it is conserved up to
humans, is involved in different cellular processes that act during
different phases of the life cycle, and because null mutants are
available that allow us to test the functions of phosphorylation in
all these phases. Using mass spectrometric analysis of immuno-
precipitated BicD and BicD::GFP, we identified the serines 14,
103, 186, 285, 288, 305 and 310, and either Thr
108 or Ser
109 to be
phosphorylated. Some of the sites found here have been
determined independently by large scale screens for phospho-sites
in Drosophila Kc167 cells [30] and in Drosophila embryos [31].
To find out more on the function of the BicD phosphorylation
sites, we performed in silico analysis on them. Only three of the
experimentally identified BicD phosphosites were also predicted
with a bioinformatic analysis using the programs NetPhos [32]
and Scansite [33]. The three broad phosphorylation motif
classifications each fit one of the BicD phsophoserines. Ser
109
corresponds to a basophilic site (K/R-X-X-S/T), while Ser
288
fits an acidophilic motif (S/T-X-X-D/E), and Ser
310 corresponds
to a proline directed site (S/T-P). Very recently, a study on
mitotic phosphorylation identified the unique phosphorylation
motif S-G/A-X-K/R [29]. While the kinase for this site is yet
unknown, the Ser
103 matches this consensus phosphorylation
motif.
In addition, we found that Ser
14 is a perfect match to a Polo
kinase target site D/E-X-S/T-W-X-D/E [22]. However, neither
Figure 4. The BicD
A40V, S103D mutant phenocopies the BicD
null allele. A normally sized fly with one copy of wild type BicD from the CyO
chromosome (A) compared with smaller BicD
A40V, S103D (B) and BicD
null (C) siblings. Note that these two mutants also display short sternopleural and
scutellar bristles. Panels D–H: Nail polish imprints of eyes of adult BicD mutants. D: rescue BicD
wt. E: BicD
A40V, S103D. F: BicD
null. G: BicD
A40V, S103A. H:
BicD
A40V, S103F. The black bar in panel D indicates 15 mm.
doi:10.1371/journal.pone.0004552.g004
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suggesting that phosphorylation of this residue is not required for
proper BicD function. This finding is surprising, because a recent
report suggested polo kinase to be involved in polarized transport
during oogenesis, where Polo could activate BicD by phosphor-
ylation specifically during oocyte differentiation [6]. Recently, the
human Glycogen synthase kinase-3b (GSK-3b) was reported to
form complexes with human BicD1 in a kinase activity-dependent
manner [8], but the phosphorylated serines identified in this study
(Figure 1E) do not fit the known GSK-3b consensus sequence S/
T-X-X-X-S/T [34].
Our systematic in vivo analysis of BicD phosphorylation
mutants revealed that none of these eight phosphorylation sites
is essential for any BicD function, and that, with the exception of
the Ser
310 substitutions, global BicD phosphorylation levels
remain unchanged in the tested mutants. One explanation for
this could be that the hyperphosphorylated isoform contains
multiple phosphorylation events between Ser
14 and Ser
288 and
that the absence of a single one of them does not alter the
isoform mobility. The exception is the serine 310. Surprisingly,
BicD phosphorylation is markedly reduced in both, the S310A
mutant that abolishes phosphorylation and the phospho-mimic
S310D mutant. Even though S310 is crucial for overall BicD
phosphorylation levels, this seems not to affect BicD activity
much, as Ser
310 mutants appear normal, further arguing against
critical roles of BicD phosphorylation on its activity. In contrast,
the A40V substitution that shows a similar reduction of total
BicD phosphorylation, also greatly reduces the functionality of
BicD. This suggests that the loss of phosphorylation in this
mutant is a side effect or a consequence, rather than the cause of
the loss-of-function, and that the bulkier side chain of valine
causes a structural change in the mutant protein and that this
inactivates the protein directly. Limited redundancy tests showed
that in the case of the serines 285/288, and 305/310, which we
found to be doubly phosphorylated, neither site is required for
BicD function (Table 1). Similarly, the five serines 33–45 in the
region around the A40V mutation are also dispensable for
essential BicD activity.
Interestingly, it was a genetic screen for a suppressor of the
female sterile and partially phosphorylation defective BicD
A40V
mutant that lead to the isolation of the Su(66) mutant that
revealed the only identifiable function of BicD phosphorylation.
We identified this mutation as a S103F substitution in the
BicD
A40V background and we showed that this substitution is
sufficient to restore the critical functions of BicD. The analysis of
additional Ser
103 substitutions in the BicD
A40V background
provided further evidence that Ser
103, and possibly its phos-
phorylation, play a modulating role on BicD function. Strikingly,
these mutants exhibited very different phenotypes: while the
S103A substitution does not change the PA66 phenotype, the
S103D mutation inactivates the BicD
A40V protein, causing
BicD
A40V, S103D to behave as a null mutant. The suppression
effect of the S103F mutation in Su(66) cannot be caused by the
absence of phosphorylation of Ser
103, because the S103A
substitution is neutral and does not change the PA66 phenotype.
Instead, the results suggest that the bulky side chain of
phenylalanine introduces a structural change in the mutant
protein that compensates for the loss of function caused by the
A40V mutation. How this substitution can suppress over the
relatively large distance of some 60 amino acids in the primary
structure is presently unknown. However, Ser
103 is located at the
beginning of a predicted coiled-coil motif of BicD (Figure 1D),
and it is tempting to assume that phosphorylation of Ser
103 may
regulate the formation of this coiled-coil region. Unfortunately,
an earlier functional analysis of coiled coil regions of BicD did
not test the importance of this particular coiled coil domain and
only included one of the phosphoserines, S186 [35].
At the onset of our experiments we envisioned that individual
phosphorylation events may control individual localization
processes. The fact that all the biochemically identified
phosphosites are non-essential for normal BicD function in all
the different processes examined, however, suggests that most of
the phosphorylation events are either fortuitous or play only
minor modulating roles. The only modulating role we could find
so far is one that we identified with tools created by a classical
genetic approach, isolating a suppressor mutation that can
restore the activity of a partially inactivated and hypopho-
sphorylated variant of BicD. In this genetically sensitized
background, the 103 position that gets phosphorylated in the
wild type protein becomes decisive for the function of the entire
protein. Interestingly, this Ser is also the only one that is fully
conserved in mice and humans. According to our findings on
BicD phosphorylation, the identification of protein phosphory-
lation sites needs to be treated with caution as such sites are often
not crucial for the function of a protein.
Figure 5. Substitutions in amino acid 103 of BicD modulate the
dominant BicD
2 phenotype. Embryos were collected from mothers
hemizygous the dominant BicD
2 allele, and carrying one copy of
transgenic BicD
wt, BicD
S103A, BicD
S103D,o rBicD
S103F. The embryos were
scored for anterior defects and classified according to the denoted
categories. N: total number of embryos counted. The flies and the
embryos were raised at 25uC and shifted to 18uC one day before egg
collection.
doi:10.1371/journal.pone.0004552.g005
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Isolation of genomic DNA and sequencing of the Su(66)
region
DNA from a pool of 15 flies was isolated according to [36]. The
coding sequences of BicD and four proximal neighboring genes
were amplified by PCR, skipping 7 kb of the first, large BicD
intron. All PCR products were purified and sequenced on an ABI
Prism 3100 Sequence Analyzer (Applied Biosystems).
Generation of vectors, in vitro mutagenesis and
transgenesis
We constructed the pw+SNattB vector that is designed to harbor
constructs driven by their own promoter. pw+SNattB contains a
multiple cloning site, a white
+ selectable marker, a loxP site, and an
attB fragment that allows its integration into attP landing platforms
[37] using the phiC31 integrase. Briefly, the UAS-SV40 cassette
from pUASTattB [37] was replaced with a modified multiple
cloning site of pLitmus28 (New England Biolabs) to yield
pw+SNattB. The sequence is available from the EMBL/GenBank
data libraries under accession no. EU729722. A similar strategy
was used to construct pUAS-K10attB that is useful for gene
expression in the female germline using the UAS-Gal4 system.
The UAS-SV40 cassette was removed from pUASTattB [37] and
replaced with the UASp cassette from pUASp [38] to yield pUAS-
K10attB. The sequence is available from the EMBL/GenBank
data libraries under accession no. EU729723.
The mini-BicD::GFP fusion construct [21] was transferred as
KpnI/NotI fragment into pw+SNattB. The BicD 39 part with the
GFP fusion was then replaced with the corresponding native
2.75 kb BicD 39 part lacking GFP that was taken from pBS4.2RV39
[24]. This yielded the mini-BicD-pw+SNattB vector that served as
wild type control BicD
wt.ABsiWI/AgeI fragment of mini-BicD::GFP
was subcloned into pLitmus28 (New England Biolabs), and the
mutations were introduced in this construct by high fidelity PCR
using suitable primers. Plasmids containing the correct mutations
were further verified by sequencing. The individual mutations
were then transferred into mini-BicD-pw+SNattB to replace the
respective wild type sequence. The fragments containing the
mutations S14A/D–S54A were cloned using BsiWI/EcoRIo r
BsiWI/PshAI, while S84A–S310A/D were transferred using
EcoRI/BstEII or PshAI/BstEII. Most clones were error-free,
however, a small number showed 1–3 nucleotide long deletions
at the PshAI site in the intron 1.
These BicD mutants were introduced into attP landing platforms
using the phiC31 integrase [37]. The mutants S33A, S34A, S36A,
S45A, multiple, A40V, S103A/D/F, A40V+S103A/D/F and the
wild type control were integrated into the landing platform ZH-
102F on the fourth chromosome. S14A/D, S51A, S84A, S109A,
S186A, S285A, S288A, S305A, S310A/D and the double mutants
S285A/S288A and S305A/S310A were inserted into ZH-64A on
the third chromosome, and S39A in ZH-2A on the X
chromosome. All transgenic constructs in the flies were verified
by preparation of genomic DNA and sequencing of the relevant
regions containing the mutation(s).
Fly stocks
The landing platforms and the integrases were described [37].
The BicD
null allele BicD
r5 was described earlier [20], and
Df(2L)Exel7068 was obtained from Bloomington Stock Center
(stock no. 7838). All BicD mutants generated for this study were
kept as stocks with the BicD
r5 allele on the second chromosome
(genotype w; BicD
r5 cn/SM1; +; + with a BicD transgene on the 1
st,
3
rd or 4
th chromosome as described above). Males were crossed to
w; Df(2L)Exel7068/CyO b females as needed to generate flies
carrying one copy of a BicD construct in a hemizygous BicD
r5
background. These progeny were then used for the experiments.
Eye imprints and embryo cuticle preparations
The eye imprints were done as described in [39]. Images were
recorded on a Leica DM6000 B microscope using a 406 DIC
objective. For cuticle preparations, embryos were collected for
24 h at 18uC from w; BicD
2/BicD
r5 cn; +; att-102F{BicD
mutant}/+
mothers, with BicD
mutant as indicated in Figure 5. The embryos
were aged for 24 h at 25uC, and cuticles were prepared as
described [40], mounted in a 1:1 mixture of lactic acid:Hoyer’s
medium and incubated at 58uC for 30 h. Cuticle phenotypes were
scored on a Nikon Eclipse E600 microscope.
Immunostainings
Immunohistochemical stainings were essentially done as
described earlier [4], with denoted modifications. After fixation,
ovaries were incubated in PBTM (16PBS with 0.2% Tween-20,
0.1% Triton X-100 and 5% non-fat dry milk), and then with the
appropriate antibodies in PBTM for 4 hours at room temperature.
Mouse monoclonal anti-BicD antibodies 4C2 and 1B11 [4] were
used each at 1:15 dilution. The secondary Cy3-conjugated anti-
mouse antibodies (Jackson ImmunoResearch) was used at a
dilution of 1:1,000. During the final washing steps, DNA and F-
actin were stained with 2.5 mg/ml Hoechst 33258 (Molecular
Probes) and 0.05 mg/ml FITC-conjugated phalloidine (Molecular
Probes), respectively. The ovarioles were embedded in Aqua-
mount (Polysciences), and images were recorded using a Leica
DM6000 B fluorescence microscope or a Leica TCS-SP2 confocal
microscope. To exclude artifacts resulting from small differences in
buffers and incubation times, all samples were processed
simultaneously, and images were recorded using identical settings
on the microscope and the software.
Large scale immunoprecipitations and mass
spectrometry
Embryos were collected during 12 hour time periods, dechor-
ionated and stored at 280uC. Ovaries from 10 g of flies were
collected as described [41]. The egg chambers were washed twice
with IP buffer (25 mM HEPES pH 7.4, 150 mM NaCl, 0.5 mM
EDTA, 1 mM DTT, supplemented with complete protease
inhibitors; Roche) and frozen in liquid nitrogen. In a glass
homogenizer, 4 g of embryos or 3.5 ml of ovaries were
homogenized in 8 ml (3.5 ml) IPpi buffer (IP buffer including
phosphatase inhibitors 0.3 mM sodium orthovanadate, 2 mM
sodium molybdate, 50 mM sodium fluoride). The homogenate
was centrifuged for 1 h at 16,000 g at 4uC. The soluble phase was
centrifuged again for 25 min at 16,000 g at 4uC. Two hundred ml
GammaBind Plus Sepharose beads (GE Healthcare) were washed
three times in PBS and incubated with 4 ml 1B11 anti-BicD
antibody for two hours. Beads with bound antibodies were washed
three times in PBS and once in IPpi buffer, added to the
homogenate supernatant and incubated for 3 h at 4uC with
constant mixing. The beads were then washed six times with IP
buffer. Finally, the beads were resuspended in Nu-PAGE sample
buffer (Invitrogen) containing 0.1 M DTT, boiled for 5 min, and
proteins were separated by SDS PAGE. The gel was stained with
Coomassie Blue (Invitrogen), bands of interest were excised, and
proteins were digested in gel with sequencing grade trypsin
(10 ng/ml; Promega) over night at room temperature. Peptides
were extracted from the gel with 20% formic acid (FA) by
incubation for 15 min at room temperature and analyzed by
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capillary ESI source (Bruker Daltonics) equipped with an Alliance
HT2795 HPLC system from Waters). CID spectra interpretation
was performed with the Phenyx software (GeneBio) using the
Uniprot Drosophila protein database, release 54.0.
To immunoprecipitate BicD::GFP from embryonic extracts,
anti-GFP antibodies were coupled covalently to Sepharose beads.
One hundred ml GammaBind Plus Sepharose beads were washed
three times in PBS and incubated with 2 ml anti-GFP antibody
(mouse monoclonal 3E6, gift from A. Marcil, BRI, Montreal) for
two hours. Beads with bound antibody were washed three times in
PBS, and finally resuspended in 400 ml PBS. To this, 100 ml
disuccinimidyl suberate solution (13 mg/ml in DMSO; Pierce
Biotechnology) was added and incubated for 1 h with constant
mixing. The beads were sedimented by centrifugation for 3 min at
1,300 g, washed once with 0.2 M ethanolamine pH 8.0 for 2 min
and another time for 2 hours with constant mixing. Beads were
sedimented and washed twice with 0.1 M glycine pH 2.8 for
10 min, and then 3 times 10 min with PBS. Finally, the beads
were resuspended in RIPApi buffer (50 mM Tris-HCl pH 8.5,
300 mM NaCl, 0.1% SDS, 0.5% deoxycholate, 1% Nonidet-P40,
1 mM EDTA supplemented with protease and phosphatase
inhibitors). Extracts of BicD::GFP embryos in RIPApi buffer were
obtained as described above, and incubated with the anti-GFP
beads over night at 4uC with constant mixing. The beads were
washed on ice six times in RIPApi buffer and once for 3 min on
ice in 0.1 M glycine pH 2.8. Beads were then sedimented by
centrifugation, and bound proteins were eluted by incubation with
8 M urea/50 mM Tris-HCl pH 8.0 for 5 min at room temper-
ature. The elution was repeated once, and the fractions were
pooled. DTT was added to 5 mM, and the mixture was incubated
at 37uC for 45 min. Sulfhydryl groups were derivatized for 30 min
at 37uC in the dark by addition of 0.5 M iodoacetamide to
12.5 mM. The proteins were precipitated with acetone, resus-
pended and digested with trypsin (4 ng/ml) over night at room
temperature. The digest was acidified with 20% FA and incubated
with TiO2 slurry in 1.56loading buffer (3.7 mg/ml TiO2 in 1.5%
trifluoroacetic acid, 60% acetonitrile (MeCN), 1.5 M lactic acid)
for 15 min. Beads were washed once in 16 loading buffer and
twice with 5% MeCN. Bound peptides were eluted for 5 min with
50 mM phosphate, 5 mM sodium orthovanadate, 1 mM NaF at
pH 10.5, acidified with 20% FA and dried in a vacuum centrifuge.
Peptides were reconstituted in 25 ml 20% FA, and 20 ml were
analyzed by nano-LC-MS/MS (LTQ-orbitrap-XL equipped with
a nanospray probe and two Rheos micro/nanoflow HPLC
systems; ThermoFisher Scientific). MS/MS spectra were searched
with Phenyx software (GeneBio) against the Uniprot-Swissprot
Drosophila melanogaster database, version 54.6. All identifications on
phosphopeptides were manually validated for correctness.
Small scale immunoprecipitations and western blotting
To prepare ovary extracts, ovaries from 1–2 day old females
were dissected in Drosophila Ringer’s solution (182 mM KCl,
46 mM NaCl, 3 mM CaCl2, 10 mM Tris-HCl, pH 7.2) and snap-
frozen on dry ice. For every sample, 35 ovary pairs were used,
except for BicD
A40V and BicD
A40V, S103A, where 70 pairs were used
each, and OreR with 90 pairs. The ovaries were homogenized in
500 ml RIPApi buffer, and the homogenate was centrifuged twice
for 5 min at 16,000 g at 4uC. The supernatant was combined with
30 ml of each anti-BicD antibody 1B11 and 4C2 and incubated for
2 h at 4uC with constant mixing. GammaBind Plus Sepharose
beads were resuspended in RIPApi buffer, and 30 ml of this
mixture was added to the ovary extracts and incubated for 1.5 h at
4uC with constant mixing. The beads were allowed to sediment by
gravity and were washed 4 times with wash buffer 1 (RIPApi with
only 0.5% Nonidet P-40).
For phosphatase treatment, beads were washed twice with wash
buffer 1, once with wash buffer 2 (wash buffer 1 lacking
phosphatase inhibitors) and once in a 1:1 mixture of wash buffer
2 and NEB3 buffer (100 mM NaCl, 50 mM Tris-HCl, 10 mM
MgCl2, 1 mM DTT, pH 7.9; New England Biolabs). The beads
were split into 3 portions, resuspended in 30 ml NEB3 buffer, and
incubated at 37uC for 1 h with 10 units of calf intestinal
phosphatase (CIP; New England Biolabs). Controls were incubat-
ed without CIP, and with CIP in the presence of inhibitors
(10 mM Na3VO4 and 4 mM Na2MoO4). The reaction was
stopped by washing the beads 3 times with wash buffer 2
containing 1 mM EDTA. Finally, the beads were resuspended in
26 sample buffer (100 mM Tris-HCl pH 6.8, 20% glycerol, 4%
SDS, 0.2 M DTT and a trace amount of bromophenol blue) and
boiled for 5 min before being loaded on a gel.
To analyze ovary extracts without IP, ovaries were dissected
and extracts were prepared as described [42]. Phospho-isoforms of
BicD were separated on standard 8.5% polyacrylamide gels
(Acrylamide:Bis=95:1) lacking SDS, which was only provided in
the running buffer. Gels were run at 20 mA in the stacking gel and
at 38 mA in the separating gel with cooling to 15uC, using a
Protean II xi cell (Bio-Rad). After transferring the proteins to
nitrocellulose membranes, BicD was detected using the mouse
anti-BicD antibodies 1B11 and 4C2 at a 1:20 dilution each.
Horseradish peroxidase-conjugated anti-mouse antibodies (GE
Healthcare) were used at a dilution of 1:5,000. The blots were
probed with ECL plus reagents (GE Healthcare), and chemilumi-
nescence signal was detected using a LAS-1000 detection system
(Fujifilm). Western blots were evaluated using AIDA software
(Raytest GmbH).
Supporting Information
Figure S1 Effect of amino acid 103 on BicD localization
Found at: doi:10.1371/journal.pone.0004552.s001 (0.57 MB
PDF)
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